Nomura Holdings, Inc. (NMR) Stock Competitors & Peer Comparison
See (NMR) competitors and their performances in Stock Market.
Peer Comparison Table: Financial - Capital Markets Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NMR | $9.41 | +0.10% | 27.4B | 11.74 | $0.80 | +3.44% |
| MS-PL | $19.36 | +0.16% | 340.7B | 1.55 | $12.47 | +1.86% |
| MS-PQ | $25.40 | -0.08% | 339.2B | 2.03 | $12.50 | +1.86% |
| MS-PP | $25.06 | -0.16% | 338.9B | 2.01 | $12.47 | +1.86% |
| MS-PO | $16.80 | -0.28% | 338.9B | 1.35 | $12.47 | +1.86% |
| GS-PC | $19.40 | +0.32% | 333.4B | 0.30 | $65.55 | +1.59% |
| MS | $210.97 | -2.10% | 332.8B | 17.05 | $12.37 | +1.86% |
| GS | $1,057.92 | -0.69% | 311.4B | 16.29 | $64.79 | +1.59% |
| GS-PD | $19.08 | -0.22% | 203.5B | 0.29 | $65.55 | +1.59% |
| GS-PA | $19.34 | -0.31% | 200B | 0.34 | $56.27 | +1.59% |
Stock Comparison
NMR vs MS-PL Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MS-PL has a market cap of 340.7B. Regarding current trading prices, NMR is priced at $9.41, while MS-PL trades at $19.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MS-PL's P/E ratio is 1.55. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PL's ROE of +0.23%. Regarding short-term risk, NMR is more volatile compared to MS-PL. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PL's competition here
NMR vs MS-PQ Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MS-PQ has a market cap of 339.2B. Regarding current trading prices, NMR is priced at $9.41, while MS-PQ trades at $25.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MS-PQ's P/E ratio is 2.03. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PQ's ROE of +0.23%. Regarding short-term risk, NMR is more volatile compared to MS-PQ. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PQ's competition here
NMR vs MS-PP Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MS-PP has a market cap of 338.9B. Regarding current trading prices, NMR is priced at $9.41, while MS-PP trades at $25.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MS-PP's P/E ratio is 2.01. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PP's ROE of +0.23%. Regarding short-term risk, NMR is more volatile compared to MS-PP. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PP's competition here
NMR vs MS-PO Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MS-PO has a market cap of 338.9B. Regarding current trading prices, NMR is priced at $9.41, while MS-PO trades at $16.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MS-PO's P/E ratio is 1.35. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PO's ROE of +0.23%. Regarding short-term risk, NMR is more volatile compared to MS-PO. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PO's competition here
NMR vs GS-PC Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, GS-PC has a market cap of 333.4B. Regarding current trading prices, NMR is priced at $9.41, while GS-PC trades at $19.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas GS-PC's P/E ratio is 0.30. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PC's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to GS-PC. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PC's competition here
NMR vs MS Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MS has a market cap of 332.8B. Regarding current trading prices, NMR is priced at $9.41, while MS trades at $210.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MS's P/E ratio is 17.05. In terms of profitability, NMR's ROE is +0.10%, compared to MS's ROE of +0.23%. Regarding short-term risk, NMR is less volatile compared to MS. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MS's competition here
NMR vs GS Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, GS has a market cap of 311.4B. Regarding current trading prices, NMR is priced at $9.41, while GS trades at $1,057.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas GS's P/E ratio is 16.29. In terms of profitability, NMR's ROE is +0.10%, compared to GS's ROE of +0.15%. Regarding short-term risk, NMR is less volatile compared to GS. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GS's competition here
NMR vs GS-PD Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, GS-PD has a market cap of 203.5B. Regarding current trading prices, NMR is priced at $9.41, while GS-PD trades at $19.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas GS-PD's P/E ratio is 0.29. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PD's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to GS-PD. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PD's competition here
NMR vs GS-PA Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, GS-PA has a market cap of 200B. Regarding current trading prices, NMR is priced at $9.41, while GS-PA trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas GS-PA's P/E ratio is 0.34. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PA's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to GS-PA. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PA's competition here
NMR vs SCHW Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SCHW has a market cap of 178.5B. Regarding current trading prices, NMR is priced at $9.41, while SCHW trades at $102.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SCHW's P/E ratio is 19.48. In terms of profitability, NMR's ROE is +0.10%, compared to SCHW's ROE of +0.19%. Regarding short-term risk, NMR is less volatile compared to SCHW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SCHW's competition here
NMR vs SCHW-PJ Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SCHW-PJ has a market cap of 177.5B. Regarding current trading prices, NMR is priced at $9.41, while SCHW-PJ trades at $17.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SCHW-PJ's P/E ratio is 3.30. In terms of profitability, NMR's ROE is +0.10%, compared to SCHW-PJ's ROE of +0.19%. Regarding short-term risk, NMR is more volatile compared to SCHW-PJ. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SCHW-PJ's competition here
NMR vs SCHW-PD Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SCHW-PD has a market cap of 177.3B. Regarding current trading prices, NMR is priced at $9.41, while SCHW-PD trades at $24.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SCHW-PD's P/E ratio is 4.60. In terms of profitability, NMR's ROE is +0.10%, compared to SCHW-PD's ROE of +0.19%. Regarding short-term risk, NMR is more volatile compared to SCHW-PD. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SCHW-PD's competition here
NMR vs HOOD Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, HOOD has a market cap of 89.4B. Regarding current trading prices, NMR is priced at $9.41, while HOOD trades at $100.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas HOOD's P/E ratio is 47.96. In terms of profitability, NMR's ROE is +0.10%, compared to HOOD's ROE of +0.22%. Regarding short-term risk, NMR is less volatile compared to HOOD. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HOOD's competition here
NMR vs GS-PJ Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, GS-PJ has a market cap of 68.9B. Regarding current trading prices, NMR is priced at $9.41, while GS-PJ trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas GS-PJ's P/E ratio is 0.49. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PJ's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to GS-PJ. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PJ's competition here
NMR vs MS-PA Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MS-PA has a market cap of 67.2B. Regarding current trading prices, NMR is priced at $9.41, while MS-PA trades at $19.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MS-PA's P/E ratio is 1.53. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PA's ROE of +0.23%. Regarding short-term risk, NMR is more volatile compared to MS-PA. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PA's competition here
NMR vs MS-PI Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MS-PI has a market cap of 66.5B. Regarding current trading prices, NMR is priced at $9.41, while MS-PI trades at $24.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MS-PI's P/E ratio is 2.00. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PI's ROE of +0.23%. Regarding short-term risk, NMR is more volatile compared to MS-PI. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PI's competition here
NMR vs MS-PF Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MS-PF has a market cap of 65.1B. Regarding current trading prices, NMR is priced at $9.41, while MS-PF trades at $25.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MS-PF's P/E ratio is 2.02. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PF's ROE of +0.23%. Regarding short-term risk, NMR is more volatile compared to MS-PF. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PF's competition here
NMR vs GS-PK Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, GS-PK has a market cap of 64.7B. Regarding current trading prices, NMR is priced at $9.41, while GS-PK trades at $25.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas GS-PK's P/E ratio is 0.49. In terms of profitability, NMR's ROE is +0.10%, compared to GS-PK's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to GS-PK. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GS-PK's competition here
NMR vs MS-PE Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MS-PE has a market cap of 64.3B. Regarding current trading prices, NMR is priced at $9.41, while MS-PE trades at $25.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MS-PE's P/E ratio is 2.03. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PE's ROE of +0.23%. Regarding short-term risk, NMR is more volatile compared to MS-PE. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PE's competition here
NMR vs MS-PK Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MS-PK has a market cap of 63.8B. Regarding current trading prices, NMR is priced at $9.41, while MS-PK trades at $23.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MS-PK's P/E ratio is 1.88. In terms of profitability, NMR's ROE is +0.10%, compared to MS-PK's ROE of +0.23%. Regarding short-term risk, NMR is more volatile compared to MS-PK. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check MS-PK's competition here
NMR vs RJF Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, RJF has a market cap of 32.8B. Regarding current trading prices, NMR is priced at $9.41, while RJF trades at $168.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas RJF's P/E ratio is 15.33. In terms of profitability, NMR's ROE is +0.10%, compared to RJF's ROE of +0.17%. Regarding short-term risk, NMR is more volatile compared to RJF. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check RJF's competition here
NMR vs LPLA Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, LPLA has a market cap of 26.2B. Regarding current trading prices, NMR is priced at $9.41, while LPLA trades at $328.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas LPLA's P/E ratio is 15.97. In terms of profitability, NMR's ROE is +0.10%, compared to LPLA's ROE of +0.17%. Regarding short-term risk, NMR is less volatile compared to LPLA. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check LPLA's competition here
NMR vs TW Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, TW has a market cap of 21.4B. Regarding current trading prices, NMR is priced at $9.41, while TW trades at $100.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas TW's P/E ratio is 27.24. In terms of profitability, NMR's ROE is +0.10%, compared to TW's ROE of +0.14%. Regarding short-term risk, NMR is less volatile compared to TW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check TW's competition here
NMR vs CRCL Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, CRCL has a market cap of 17.5B. Regarding current trading prices, NMR is priced at $9.41, while CRCL trades at $65.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas CRCL's P/E ratio is -20.46. In terms of profitability, NMR's ROE is +0.10%, compared to CRCL's ROE of -0.03%. Regarding short-term risk, NMR is less volatile compared to CRCL. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check CRCL's competition here
NMR vs IREN Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, IREN has a market cap of 14.3B. Regarding current trading prices, NMR is priced at $9.41, while IREN trades at $40.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas IREN's P/E ratio is -27.92. In terms of profitability, NMR's ROE is +0.10%, compared to IREN's ROE of +0.03%. Regarding short-term risk, NMR is less volatile compared to IREN. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check IREN's competition here
NMR vs FUTU Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, FUTU has a market cap of 13.7B. Regarding current trading prices, NMR is priced at $9.41, while FUTU trades at $98.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas FUTU's P/E ratio is 10.81. In terms of profitability, NMR's ROE is +0.10%, compared to FUTU's ROE of +0.27%. Regarding short-term risk, NMR is less volatile compared to FUTU. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check FUTU's competition here
NMR vs EVR Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, EVR has a market cap of 12.9B. Regarding current trading prices, NMR is priced at $9.41, while EVR trades at $335.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas EVR's P/E ratio is 17.98. In terms of profitability, NMR's ROE is +0.10%, compared to EVR's ROE of +0.41%. Regarding short-term risk, NMR is less volatile compared to EVR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check EVR's competition here
NMR vs VIRT Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, VIRT has a market cap of 12.2B. Regarding current trading prices, NMR is priced at $9.41, while VIRT trades at $56.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas VIRT's P/E ratio is 8.49. In terms of profitability, NMR's ROE is +0.10%, compared to VIRT's ROE of +0.36%. Regarding short-term risk, NMR is less volatile compared to VIRT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check VIRT's competition here
NMR vs HUT Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, HUT has a market cap of 11.4B. Regarding current trading prices, NMR is priced at $9.41, while HUT trades at $100.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas HUT's P/E ratio is -55.15. In terms of profitability, NMR's ROE is +0.10%, compared to HUT's ROE of -0.23%. Regarding short-term risk, NMR is less volatile compared to HUT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HUT's competition here
NMR vs JEF Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, JEF has a market cap of 11.2B. Regarding current trading prices, NMR is priced at $9.41, while JEF trades at $55.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas JEF's P/E ratio is 14.95. In terms of profitability, NMR's ROE is +0.10%, compared to JEF's ROE of +0.09%. Regarding short-term risk, NMR is less volatile compared to JEF. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check JEF's competition here
NMR vs SF-PB Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SF-PB has a market cap of 11.2B. Regarding current trading prices, NMR is priced at $9.41, while SF-PB trades at $22.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SF-PB's P/E ratio is 3.47. In terms of profitability, NMR's ROE is +0.10%, compared to SF-PB's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to SF-PB. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SF-PB's competition here
NMR vs BGCG Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, BGCG has a market cap of 9.7B. Regarding current trading prices, NMR is priced at $9.41, while BGCG trades at $26.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas BGCG's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to BGCG's ROE of +0.00%. Regarding short-term risk, NMR is more volatile compared to BGCG. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check BGCG's competition here
NMR vs HLI Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, HLI has a market cap of 9.7B. Regarding current trading prices, NMR is priced at $9.41, while HLI trades at $140.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas HLI's P/E ratio is 18.52. In terms of profitability, NMR's ROE is +0.10%, compared to HLI's ROE of +0.19%. Regarding short-term risk, NMR is less volatile compared to HLI. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HLI's competition here
NMR vs FRHC Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, FRHC has a market cap of 9.7B. Regarding current trading prices, NMR is priced at $9.41, while FRHC trades at $156.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas FRHC's P/E ratio is 62.76. In terms of profitability, NMR's ROE is +0.10%, compared to FRHC's ROE of +0.11%. Regarding short-term risk, NMR is less volatile compared to FRHC. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check FRHC's competition here
NMR vs SCE-PJ Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SCE-PJ has a market cap of 9.6B. Regarding current trading prices, NMR is priced at $9.41, while SCE-PJ trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SCE-PJ's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to SCE-PJ's ROE of N/A. Regarding short-term risk, NMR is more volatile compared to SCE-PJ. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SCE-PJ's competition here
NMR vs BMNR Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, BMNR has a market cap of 9.5B. Regarding current trading prices, NMR is priced at $9.41, while BMNR trades at $16.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas BMNR's P/E ratio is -6.85. In terms of profitability, NMR's ROE is +0.10%, compared to BMNR's ROE of -0.85%. Regarding short-term risk, NMR is less volatile compared to BMNR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BMNR's competition here
NMR vs BMNP Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, BMNP has a market cap of 8.9B. Regarding current trading prices, NMR is priced at $9.41, while BMNP trades at $86.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas BMNP's P/E ratio is 1011.06. In terms of profitability, NMR's ROE is +0.10%, compared to BMNP's ROE of -0.85%. Regarding short-term risk, NMR is more volatile compared to BMNP. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check BMNP's competition here
NMR vs XP Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, XP has a market cap of 8.8B. Regarding current trading prices, NMR is priced at $9.41, while XP trades at $16.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas XP's P/E ratio is 9.28. In terms of profitability, NMR's ROE is +0.10%, compared to XP's ROE of +0.22%. Regarding short-term risk, NMR is less volatile compared to XP. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check XP's competition here
NMR vs SNEX Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SNEX has a market cap of 8.2B. Regarding current trading prices, NMR is priced at $9.41, while SNEX trades at $70.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SNEX's P/E ratio is 15.77. In terms of profitability, NMR's ROE is +0.10%, compared to SNEX's ROE of +0.19%. Regarding short-term risk, NMR is less volatile compared to SNEX. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SNEX's competition here
NMR vs RIOT Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, RIOT has a market cap of 7.5B. Regarding current trading prices, NMR is priced at $9.41, while RIOT trades at $20.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas RIOT's P/E ratio is -7.54. In terms of profitability, NMR's ROE is +0.10%, compared to RIOT's ROE of -0.29%. Regarding short-term risk, NMR is less volatile compared to RIOT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check RIOT's competition here
NMR vs FIGR Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, FIGR has a market cap of 5.6B. Regarding current trading prices, NMR is priced at $9.41, while FIGR trades at $30.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas FIGR's P/E ratio is 52.45. In terms of profitability, NMR's ROE is +0.10%, compared to FIGR's ROE of +0.18%. Regarding short-term risk, NMR is less volatile compared to FIGR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check FIGR's competition here
NMR vs RJF-PA Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, RJF-PA has a market cap of 5.4B. Regarding current trading prices, NMR is priced at $9.41, while RJF-PA trades at $25.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas RJF-PA's P/E ratio is 3.54. In terms of profitability, NMR's ROE is +0.10%, compared to RJF-PA's ROE of +0.17%. Regarding short-term risk, NMR is more volatile compared to RJF-PA. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check RJF-PA's competition here
NMR vs BGC Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, BGC has a market cap of 5.3B. Regarding current trading prices, NMR is priced at $9.41, while BGC trades at $11.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas BGC's P/E ratio is 9.02. In terms of profitability, NMR's ROE is +0.10%, compared to BGC's ROE of +0.19%. Regarding short-term risk, NMR is less volatile compared to BGC. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BGC's competition here
NMR vs MC Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MC has a market cap of 5B. Regarding current trading prices, NMR is priced at $9.41, while MC trades at $67.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MC's P/E ratio is 23.62. In terms of profitability, NMR's ROE is +0.10%, compared to MC's ROE of +0.42%. Regarding short-term risk, NMR is less volatile compared to MC. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MC's competition here
NMR vs LAZ Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, LAZ has a market cap of 4.7B. Regarding current trading prices, NMR is priced at $9.41, while LAZ trades at $42.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas LAZ's P/E ratio is 18.33. In terms of profitability, NMR's ROE is +0.10%, compared to LAZ's ROE of +0.33%. Regarding short-term risk, NMR is less volatile compared to LAZ. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check LAZ's competition here
NMR vs MRX Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MRX has a market cap of 4.5B. Regarding current trading prices, NMR is priced at $9.41, while MRX trades at $62.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MRX's P/E ratio is 21.16. In terms of profitability, NMR's ROE is +0.10%, compared to MRX's ROE of +0.26%. Regarding short-term risk, NMR is less volatile compared to MRX. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MRX's competition here
NMR vs MARA Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MARA has a market cap of 4.4B. Regarding current trading prices, NMR is priced at $9.41, while MARA trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MARA's P/E ratio is -5.30. In terms of profitability, NMR's ROE is +0.10%, compared to MARA's ROE of -0.52%. Regarding short-term risk, NMR is less volatile compared to MARA. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MARA's competition here
NMR vs MKTX Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MKTX has a market cap of 4.1B. Regarding current trading prices, NMR is priced at $9.41, while MKTX trades at $114.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MKTX's P/E ratio is 14.79. In terms of profitability, NMR's ROE is +0.10%, compared to MKTX's ROE of +0.24%. Regarding short-term risk, NMR is less volatile compared to MKTX. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MKTX's competition here
NMR vs MIAX Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MIAX has a market cap of 4.1B. Regarding current trading prices, NMR is priced at $9.41, while MIAX trades at $42.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MIAX's P/E ratio is 23.10. In terms of profitability, NMR's ROE is +0.10%, compared to MIAX's ROE of +0.15%. Regarding short-term risk, NMR is less volatile compared to MIAX. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MIAX's competition here
NMR vs ETOR Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, ETOR has a market cap of 3.1B. Regarding current trading prices, NMR is priced at $9.41, while ETOR trades at $36.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas ETOR's P/E ratio is 13.19. In terms of profitability, NMR's ROE is +0.10%, compared to ETOR's ROE of +0.17%. Regarding short-term risk, NMR is less volatile compared to ETOR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check ETOR's competition here
NMR vs SF-PC Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SF-PC has a market cap of 2.2B. Regarding current trading prices, NMR is priced at $9.41, while SF-PC trades at $22.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SF-PC's P/E ratio is 3.37. In terms of profitability, NMR's ROE is +0.10%, compared to SF-PC's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to SF-PC. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SF-PC's competition here
NMR vs BGCP Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, BGCP has a market cap of 1.7B. Regarding current trading prices, NMR is priced at $9.41, while BGCP trades at $4.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas BGCP's P/E ratio is 40.27. In terms of profitability, NMR's ROE is +0.10%, compared to BGCP's ROE of +0.19%. Regarding short-term risk, NMR is less volatile compared to BGCP. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BGCP's competition here
NMR vs SF-PD Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SF-PD has a market cap of 1.7B. Regarding current trading prices, NMR is priced at $9.41, while SF-PD trades at $16.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SF-PD's P/E ratio is 2.48. In terms of profitability, NMR's ROE is +0.10%, compared to SF-PD's ROE of +0.15%. Regarding short-term risk, NMR is more volatile compared to SF-PD. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SF-PD's competition here
NMR vs CIFRW Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, CIFRW has a market cap of 1.6B. Regarding current trading prices, NMR is priced at $9.41, while CIFRW trades at $4.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas CIFRW's P/E ratio is -19.22. In terms of profitability, NMR's ROE is +0.10%, compared to CIFRW's ROE of -1.18%. Regarding short-term risk, NMR is less volatile compared to CIFRW. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check CIFRW's competition here
NMR vs HKIB Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, HKIB has a market cap of 1.5B. Regarding current trading prices, NMR is priced at $9.41, while HKIB trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas HKIB's P/E ratio is 6.68. In terms of profitability, NMR's ROE is +0.10%, compared to HKIB's ROE of +0.14%. Regarding short-term risk, NMR is less volatile compared to HKIB. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HKIB's competition here
NMR vs PWP Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, PWP has a market cap of 1.5B. Regarding current trading prices, NMR is priced at $9.41, while PWP trades at $15.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas PWP's P/E ratio is 35.73. In terms of profitability, NMR's ROE is +0.10%, compared to PWP's ROE of -0.09%. Regarding short-term risk, NMR is less volatile compared to PWP. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check PWP's competition here
NMR vs BITF Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, BITF has a market cap of 1.3B. Regarding current trading prices, NMR is priced at $9.41, while BITF trades at $2.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas BITF's P/E ratio is -5.68. In terms of profitability, NMR's ROE is +0.10%, compared to BITF's ROE of -0.70%. Regarding short-term risk, NMR is less volatile compared to BITF. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BITF's competition here
NMR vs SBET Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SBET has a market cap of 1.2B. Regarding current trading prices, NMR is priced at $9.41, while SBET trades at $6.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SBET's P/E ratio is -0.82. In terms of profitability, NMR's ROE is +0.10%, compared to SBET's ROE of -0.74%. Regarding short-term risk, NMR is less volatile compared to SBET. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SBET's competition here
NMR vs AMRK Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, AMRK has a market cap of 1.2B. Regarding current trading prices, NMR is priced at $9.41, while AMRK trades at $46.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas AMRK's P/E ratio is 155.73. In terms of profitability, NMR's ROE is +0.10%, compared to AMRK's ROE of +0.12%. Regarding short-term risk, NMR is less volatile compared to AMRK. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check AMRK's competition here
NMR vs OPY Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, OPY has a market cap of 1.1B. Regarding current trading prices, NMR is priced at $9.41, while OPY trades at $109.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas OPY's P/E ratio is 7.44. In terms of profitability, NMR's ROE is +0.10%, compared to OPY's ROE of +0.10%. Regarding short-term risk, NMR is less volatile compared to OPY. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check OPY's competition here
NMR vs COWN Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, COWN has a market cap of 1.1B. Regarding current trading prices, NMR is priced at $9.41, while COWN trades at $38.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas COWN's P/E ratio is 17.64. In terms of profitability, NMR's ROE is +0.10%, compared to COWN's ROE of +0.07%. Regarding short-term risk, NMR is more volatile compared to COWN. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check COWN's competition here
NMR vs GOLD Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, GOLD has a market cap of 1.1B. Regarding current trading prices, NMR is priced at $9.41, while GOLD trades at $37.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas GOLD's P/E ratio is 7.62. In terms of profitability, NMR's ROE is +0.10%, compared to GOLD's ROE of +0.12%. Regarding short-term risk, NMR is less volatile compared to GOLD. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GOLD's competition here
NMR vs PURR Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, PURR has a market cap of 948.9M. Regarding current trading prices, NMR is priced at $9.41, while PURR trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas PURR's P/E ratio is -1.27. In terms of profitability, NMR's ROE is +0.10%, compared to PURR's ROE of -0.34%. Regarding short-term risk, NMR is less volatile compared to PURR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check PURR's competition here
NMR vs TIGR Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, TIGR has a market cap of 836.3M. Regarding current trading prices, NMR is priced at $9.41, while TIGR trades at $4.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas TIGR's P/E ratio is 6.88. In terms of profitability, NMR's ROE is +0.10%, compared to TIGR's ROE of +0.14%. Regarding short-term risk, NMR is less volatile compared to TIGR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check TIGR's competition here
NMR vs LCLN Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, LCLN has a market cap of 789M. Regarding current trading prices, NMR is priced at $9.41, while LCLN trades at $22.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas LCLN's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to LCLN's ROE of +0.50%. Regarding short-term risk, NMR is less volatile compared to LCLN. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check LCLN's competition here
NMR vs AC Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, AC has a market cap of 652.2M. Regarding current trading prices, NMR is priced at $9.41, while AC trades at $30.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas AC's P/E ratio is 12.17. In terms of profitability, NMR's ROE is +0.10%, compared to AC's ROE of +0.03%. Regarding short-term risk, NMR is less volatile compared to AC. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check AC's competition here
NMR vs BTGO Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, BTGO has a market cap of 543M. Regarding current trading prices, NMR is priced at $9.41, while BTGO trades at $5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas BTGO's P/E ratio is -3.93. In terms of profitability, NMR's ROE is +0.10%, compared to BTGO's ROE of -0.27%. Regarding short-term risk, NMR is less volatile compared to BTGO. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BTGO's competition here
NMR vs BTBT Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, BTBT has a market cap of 537.8M. Regarding current trading prices, NMR is priced at $9.41, while BTBT trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas BTBT's P/E ratio is -1.45. In terms of profitability, NMR's ROE is +0.10%, compared to BTBT's ROE of -0.00%. Regarding short-term risk, NMR is less volatile compared to BTBT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BTBT's competition here
NMR vs ABTC Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, ABTC has a market cap of 409.4M. Regarding current trading prices, NMR is priced at $9.41, while ABTC trades at $5.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas ABTC's P/E ratio is -2.93. In terms of profitability, NMR's ROE is +0.10%, compared to ABTC's ROE of -0.30%. Regarding short-term risk, NMR is less volatile compared to ABTC. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check ABTC's competition here
NMR vs MFH Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MFH has a market cap of 390.3M. Regarding current trading prices, NMR is priced at $9.41, while MFH trades at $5.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MFH's P/E ratio is -70.63. In terms of profitability, NMR's ROE is +0.10%, compared to MFH's ROE of -0.15%. Regarding short-term risk, NMR is less volatile compared to MFH. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MFH's competition here
NMR vs FUFUW Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, FUFUW has a market cap of 387M. Regarding current trading prices, NMR is priced at $9.41, while FUFUW trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas FUFUW's P/E ratio is -0.49. In terms of profitability, NMR's ROE is +0.10%, compared to FUFUW's ROE of -0.29%. Regarding short-term risk, NMR is more volatile compared to FUFUW. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check FUFUW's competition here
NMR vs GHL Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, GHL has a market cap of 282M. Regarding current trading prices, NMR is priced at $9.41, while GHL trades at $14.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas GHL's P/E ratio is -10.27. In terms of profitability, NMR's ROE is +0.10%, compared to GHL's ROE of +0.04%. Regarding short-term risk, NMR is more volatile compared to GHL. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GHL's competition here
NMR vs CSHR Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, CSHR has a market cap of 270.5M. Regarding current trading prices, NMR is priced at $9.41, while CSHR trades at $4.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas CSHR's P/E ratio is 2.38. In terms of profitability, NMR's ROE is +0.10%, compared to CSHR's ROE of +0.26%. Regarding short-term risk, NMR is less volatile compared to CSHR. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check CSHR's competition here
NMR vs FUFU Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, FUFU has a market cap of 246.2M. Regarding current trading prices, NMR is priced at $9.41, while FUFU trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas FUFU's P/E ratio is -37.25. In terms of profitability, NMR's ROE is +0.10%, compared to FUFU's ROE of -0.29%. Regarding short-term risk, NMR is less volatile compared to FUFU. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check FUFU's competition here
NMR vs WHG Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, WHG has a market cap of 183.1M. Regarding current trading prices, NMR is priced at $9.41, while WHG trades at $19.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas WHG's P/E ratio is 12.61. In terms of profitability, NMR's ROE is +0.10%, compared to WHG's ROE of +0.06%. Regarding short-term risk, NMR is less volatile compared to WHG. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check WHG's competition here
NMR vs SWIN Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SWIN has a market cap of 160.9M. Regarding current trading prices, NMR is priced at $9.41, while SWIN trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SWIN's P/E ratio is -8.04. In terms of profitability, NMR's ROE is +0.10%, compared to SWIN's ROE of -0.03%. Regarding short-term risk, NMR is less volatile compared to SWIN. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SWIN's competition here
NMR vs AXG Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, AXG has a market cap of 139.2M. Regarding current trading prices, NMR is priced at $9.41, while AXG trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas AXG's P/E ratio is -122.14. In terms of profitability, NMR's ROE is +0.10%, compared to AXG's ROE of -0.00%. Regarding short-term risk, NMR is less volatile compared to AXG. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check AXG's competition here
NMR vs DEFT Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, DEFT has a market cap of 133.9M. Regarding current trading prices, NMR is priced at $9.41, while DEFT trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas DEFT's P/E ratio is 2.74. In terms of profitability, NMR's ROE is +0.10%, compared to DEFT's ROE of +0.32%. Regarding short-term risk, NMR is less volatile compared to DEFT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check DEFT's competition here
NMR vs TCJH Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, TCJH has a market cap of 89.6M. Regarding current trading prices, NMR is priced at $9.41, while TCJH trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas TCJH's P/E ratio is -1.61. In terms of profitability, NMR's ROE is +0.10%, compared to TCJH's ROE of -0.55%. Regarding short-term risk, NMR is less volatile compared to TCJH. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check TCJH's competition here
NMR vs SUIG Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SUIG has a market cap of 86M. Regarding current trading prices, NMR is priced at $9.41, while SUIG trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SUIG's P/E ratio is -0.20. In terms of profitability, NMR's ROE is +0.10%, compared to SUIG's ROE of -1.93%. Regarding short-term risk, NMR is less volatile compared to SUIG. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SUIG's competition here
NMR vs SRL Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SRL has a market cap of 79.6M. Regarding current trading prices, NMR is priced at $9.41, while SRL trades at $5.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SRL's P/E ratio is -41.01. In terms of profitability, NMR's ROE is +0.10%, compared to SRL's ROE of -0.07%. Regarding short-term risk, NMR is less volatile compared to SRL. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SRL's competition here
NMR vs AIFC Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, AIFC has a market cap of 79.4M. Regarding current trading prices, NMR is priced at $9.41, while AIFC trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas AIFC's P/E ratio is -3.15. In terms of profitability, NMR's ROE is +0.10%, compared to AIFC's ROE of N/A. Regarding short-term risk, NMR is less volatile compared to AIFC. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check AIFC's competition here
NMR vs TOP Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, TOP has a market cap of 75.2M. Regarding current trading prices, NMR is priced at $9.41, while TOP trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas TOP's P/E ratio is -70.89. In terms of profitability, NMR's ROE is +0.10%, compared to TOP's ROE of -0.03%. Regarding short-term risk, NMR is less volatile compared to TOP. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check TOP's competition here
NMR vs SIEB Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SIEB has a market cap of 68.8M. Regarding current trading prices, NMR is priced at $9.41, while SIEB trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SIEB's P/E ratio is -11.91. In terms of profitability, NMR's ROE is +0.10%, compared to SIEB's ROE of -0.06%. Regarding short-term risk, NMR is less volatile compared to SIEB. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SIEB's competition here
NMR vs GRDI Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, GRDI has a market cap of 68.1M. Regarding current trading prices, NMR is priced at $9.41, while GRDI trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas GRDI's P/E ratio is 3.20. In terms of profitability, NMR's ROE is +0.10%, compared to GRDI's ROE of +0.25%. Regarding short-term risk, NMR is less volatile compared to GRDI. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GRDI's competition here
NMR vs BTCS Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, BTCS has a market cap of 48.8M. Regarding current trading prices, NMR is priced at $9.41, while BTCS trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas BTCS's P/E ratio is -0.57. In terms of profitability, NMR's ROE is +0.10%, compared to BTCS's ROE of -0.73%. Regarding short-term risk, NMR is less volatile compared to BTCS. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check BTCS's competition here
NMR vs ADEX-WT Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, ADEX-WT has a market cap of 47.9M. Regarding current trading prices, NMR is priced at $9.41, while ADEX-WT trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas ADEX-WT's P/E ratio is N/A. In terms of profitability, NMR's ROE is +0.10%, compared to ADEX-WT's ROE of +0.25%. Regarding short-term risk, NMR is less volatile compared to ADEX-WT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check ADEX-WT's competition here
NMR vs DOMH Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, DOMH has a market cap of 45.1M. Regarding current trading prices, NMR is priced at $9.41, while DOMH trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas DOMH's P/E ratio is -0.24. In terms of profitability, NMR's ROE is +0.10%, compared to DOMH's ROE of -0.47%. Regarding short-term risk, NMR is less volatile compared to DOMH. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check DOMH's competition here
NMR vs PLUT Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, PLUT has a market cap of 44.1M. Regarding current trading prices, NMR is priced at $9.41, while PLUT trades at $2.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas PLUT's P/E ratio is -8.20. In terms of profitability, NMR's ROE is +0.10%, compared to PLUT's ROE of -0.29%. Regarding short-term risk, NMR is less volatile compared to PLUT. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check PLUT's competition here
NMR vs SDIG Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SDIG has a market cap of 42M. Regarding current trading prices, NMR is priced at $9.41, while SDIG trades at $2.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SDIG's P/E ratio is -3.51. In terms of profitability, NMR's ROE is +0.10%, compared to SDIG's ROE of -0.90%. Regarding short-term risk, NMR is more volatile compared to SDIG. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check SDIG's competition here
NMR vs HGBL Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, HGBL has a market cap of 40.3M. Regarding current trading prices, NMR is priced at $9.41, while HGBL trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas HGBL's P/E ratio is 11.60. In terms of profitability, NMR's ROE is +0.10%, compared to HGBL's ROE of +0.05%. Regarding short-term risk, NMR is less volatile compared to HGBL. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check HGBL's competition here
NMR vs GSIW Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, GSIW has a market cap of 39M. Regarding current trading prices, NMR is priced at $9.41, while GSIW trades at $27.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas GSIW's P/E ratio is -0.50. In terms of profitability, NMR's ROE is +0.10%, compared to GSIW's ROE of -0.57%. Regarding short-term risk, NMR is more volatile compared to GSIW. This indicates potentially higher risk in terms of short-term price fluctuations for NMR.Check GSIW's competition here
NMR vs GREE Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, GREE has a market cap of 38.4M. Regarding current trading prices, NMR is priced at $9.41, while GREE trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas GREE's P/E ratio is 5.61. In terms of profitability, NMR's ROE is +0.10%, compared to GREE's ROE of -0.12%. Regarding short-term risk, NMR is less volatile compared to GREE. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GREE's competition here
NMR vs MDBH Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MDBH has a market cap of 32M. Regarding current trading prices, NMR is priced at $9.41, while MDBH trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MDBH's P/E ratio is -1.50. In terms of profitability, NMR's ROE is +0.10%, compared to MDBH's ROE of -0.36%. Regarding short-term risk, NMR is less volatile compared to MDBH. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MDBH's competition here
NMR vs COHN Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, COHN has a market cap of 26.6M. Regarding current trading prices, NMR is priced at $9.41, while COHN trades at $12.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas COHN's P/E ratio is 1.75. In terms of profitability, NMR's ROE is +0.10%, compared to COHN's ROE of +0.32%. Regarding short-term risk, NMR is less volatile compared to COHN. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check COHN's competition here
NMR vs GRYP Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, GRYP has a market cap of 23M. Regarding current trading prices, NMR is priced at $9.41, while GRYP trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas GRYP's P/E ratio is -1.20. In terms of profitability, NMR's ROE is +0.10%, compared to GRYP's ROE of -0.16%. Regarding short-term risk, NMR is less volatile compared to GRYP. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check GRYP's competition here
NMR vs SAI Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, SAI has a market cap of 18.5M. Regarding current trading prices, NMR is priced at $9.41, while SAI trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas SAI's P/E ratio is -2.88. In terms of profitability, NMR's ROE is +0.10%, compared to SAI's ROE of -0.33%. Regarding short-term risk, NMR is less volatile compared to SAI. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check SAI's competition here
NMR vs MEGL Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, MEGL has a market cap of 9.1M. Regarding current trading prices, NMR is priced at $9.41, while MEGL trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas MEGL's P/E ratio is -11.89. In terms of profitability, NMR's ROE is +0.10%, compared to MEGL's ROE of -0.07%. Regarding short-term risk, NMR is less volatile compared to MEGL. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check MEGL's competition here
NMR vs ATIF Comparison July 2026
NMR plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NMR stands at 27.4B. In comparison, ATIF has a market cap of 7.6M. Regarding current trading prices, NMR is priced at $9.41, while ATIF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NMR currently has a P/E ratio of 11.74, whereas ATIF's P/E ratio is -2.06. In terms of profitability, NMR's ROE is +0.10%, compared to ATIF's ROE of -0.33%. Regarding short-term risk, NMR is less volatile compared to ATIF. This indicates potentially lower risk in terms of short-term price fluctuations for NMR.Check ATIF's competition here